Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiome Changes After MACE Placement and Bowel Flush Regimen in Constipated Children
NCT05821309Phase 4Recruiting
- Sponsor
- Indiana University
- Start
- Jun 2023
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol 3350 in constipation (2 arms), sponsored by Indiana University. Primary endpoint: Change in Fecal Microbiome at 8 months. Started Jun 2023; status: recruiting.
02
Drugs
polyethylene glycol 3350
03
Conditions
constipation
Beyond the preview
Go deeper on NCT05821309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05821309.